In vitro equivalence assessment of rivaroxaban tablets
Background. Thrombotic conditions and complicationsa are among the leading causes of death and disability in high-income countries. The introduction of direct oral anticoagulants into clinical practice has expanded the possibilities of anticoagulant therapy. Having a broader spectrum of indications...
Kaydedildi:
| Asıl Yazarlar: | , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Russo |
| Baskı/Yayın Bilgisi: |
ZAO "Consilium Medicum"
2025-01-01
|
| Seri Bilgileri: | Consilium Medicum |
| Konular: | |
| Online Erişim: | https://consilium.orscience.ru/2075-1753/article/viewFile/698700/217976 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|